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Ofykth. This sludy ttnalyzed the Wnetics of oxygen consump- 
tion during mnl after a maximal cardiopulmonary exercise test in 
patbnts with dilated cardtomyopatby. The prognosttc inFormation 
derived from indexes of recovery was else studied. 
Bockgnuutd. Previons studies ltsve examined the kinetics of 
oxygen eoosumptton during a short lprovety period lo 8 limited 
numher of patients. To our knowledge, no study has examined the 
prognostic inform&ion dertved from indexes of recovery. 
Me&&. We studied IS3 patients end 55 control subjects. We 
calcuhtted the ratio between total oxygen consumptiw durtq 
exercise snd recovery, the half-recovery time of peak oxygen 
consmnption, the time constant of recovery, the recovery time and 
tbe ratio hetweeo duration of exercise and recovery time. 
Reru//r. Recovery of oxygen consumption was signigcantly 
delayed in patients, and this delay was relsted lo the deg;rre of 
-I_- 
Cardiopulmonary exercise testing is widely used to appreciate 
exercise tolerance (12). In patients with congestive heart 
failure. peak oxygen consumption is :I good marker of prog 
no& and a &ul guide for the timing of cardiac transplanta- 
tion (3-S). Curiously, few studies hav; examined the kinettcs of 
expired gas during recovery in patients with dilated cardiomy 
opathy. Previous studies have been performed either in normal 
subjects (6-8) or in a limited number of patients with dilated 
cardiomyopathy and with a short recovery period (Y-12). The 
largest study (12) analyzed the kinetics of oxygen consumption 
in 72 patients hut in only 13 control subjects and during a short 
recovery period of 3 mm. Moreovc,r. the clinical relevance of 
indexes of recovery has never been studied. 
The aims of this,study were I) to analyze the kinetics of 
oxygen consumption during a prolonged recovery period after 
maximal symptom limited cxercisc in rontrol subjects and in a 
I-- -__.- _-_ 
exercise intolerance. After a median follow-up period of439 days, 
for the total study group, percent of predicted peak oxygen 
consumption (p = 0403) and ejection fraction (p = 0.03) were 
mdependent predictors of survival. In a subgroup of patients with 
moderate exercise intolerance (percent peek oxygen consumption 
MO%), the ratio between total oxygen consumption during exer- 
cise snd recovery (p = 0.013) and the ejection fraction (p = 0.013) 
were independent predictors of survtval. 
Coo&w&. The kinetics of oxygen consumption during recov- 
ery wus delay,d in patients witb dilated eardiomyopatby. Although 
indexes of recovery were not proguosttc markers in the total study 
group, the ratio hetween total oxygen eonsumptlon during exercise 
and recovery was an independent prognostic marker in patleuts 
with moderate exercise intolerance. 
(i Am Coil Cmvlid 1996;28:168-75) 
--- --- 
large group of patients with stable dilated cardiomyopathy, and 
2) to evaluate the prognostic information of indexes of recov- 
cry in ambulatory patients with stable d&ted cardiomyopathy. 
We postulated that indexes that analyze exercise and recovery 
periods are more precise than indexes that analyze only the 
exercise period, particularly in a subgroup of patients with :I 
moderate risk of major cardiac events. These indexes, easy to 
determine, could be new interesting markers of exercise intol- 
erance. 
Methods 
Study group. Ambulatory patients with dilated cardiomy- 
opathy of various etiologies were studied. All the patients were 
symptomatically stable during the preceding 2 months and 
wcrc in New York Hcart Association functional class II or 111. 
Dilated cardiomyopathy was defined as a left ventricular 
end-diastolic diameter ~58 mm on echocardiography. Left 
ventricular ejection fraction was determmed by radionuclidc 
angiogtaphy or contrast ventriculography. Patients were ex- 
cluded if they had significant pulmonary disease. intermittent 
claudication or angina during exercise that could lead to 
nonmaximal exercise. Patients were classified into three sub 
groups according to peak oxygen consumption (peak oxygen 
consumption 215 mkmin per kg = group I. ~15 and 
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>I0 ml/min per kg = group 2 and s 10 ml/min per kg - group 
3). We used these cutoff values according to those set by the 
guidelines for heart transplantation (13). Patients were com- 
pared with 55 healthy normal subjects who were taking n(\ 
medications, had no history of cardiovascular and puhnonzry 
diseases and had normal tindings on clinical examinaticc.0 _!--- $ urn 
Control spbjects \Gere classitied into two subgroups according 
to age: young 18 to 535 years old [mean i: SD 25 f 5.51, n = 
30 123 men, 7 women]) and old >35 to 71 years old [mean 
48.3 -C 11.21, n = 25 [ 18 men, ‘I women]). 
Exerelse protocol. Exercise eras performed in the morning 
after a light standard meal on an upright electromagnetically 
braked bicycle (Hellige, Meditronic 35) using a continuous 
protocol (30 W the 1st 3 min; thereafter, an increment of 
LO W/min). All study parzicipants had to cycle at the rate of 60 
rcvolutionslmin at each stage. Patients were allowed to con- 
tinue until respiratory exchang: ratio (defined as the ratio 
between oxygen consumption and carbon dioxide production) 
was >I. Exercise was terminated at the point when the 
participant was unable to corttinue, which for all control 
subjects was the result of fatigue and for all patients the result 
of either dyspnea or the leg or general fatigue, or both dyspnea 
and leg or general fatigue. After the end of exercise, partici- 
pants remained seated on the bicycle until the respiratory 
exchange ratio was < 1 For 220 s. In patients, medications were 
not withdrawn before the test and no patient was taking part in 
a regular exercise program. Smoking within 2 h before the test 
was not permitted. Heart rate was continuously recorded on a 
12-lead electrocardiogram (Marquette Electronics Inc. Case 
15). Blood pressure was measured every 2 min and at peak 
exercise with a mercury sphygmomanometer. The data for gas 
exchange were collected on a breath by breath basis using a 
computerized c;stem (Medical Graphics Corporation, CPX 
system). Oxygen fraction was measured by using a permanent 
zirconium oxide electrochemical cell and the carbon dioxide 
fractior was measured by using a dual-beam infrared ab)rp- 
tion chamber. Both analyzers were calibrated by using stal;- 
dard gas mixtures before each exercise test. 
Measures. All data for each subject were averaged every 
10 s and transferred to a computer for the dctcrmination of 
several variables (Fig. I). Oxygen consumption at rest was 
defined as the average of the last 2 min before the beginr.;ng of 
excrcisc. Anaerobic threshold was determined by ihc V tlopc 
method and by analyzing ratio of mrnute ventilation against 
oq’gen consumption and ratio of minute ven:ilation against 
carbon dioxide production. Peak oxygen consumption and 
peak carbon dioxide production were defined as the average 
value obtained during the last 10 s of exercise. Predicted value 
of maximal oxygen consumption was catalated by using the 
Wasserman equation, normalizing maximal oxygen consump 
tion for age, gender, weight and height (14). The oxygen 
consumption-time relation during recovery was fitted to a 
monoexponential curve by a nonlinear curve-fittmg pmgrdm 
by using the equation: Oxygen consur@oo = A+Be”, where 
A and B were constants, t was the Flapsed time after peak 
exercise and I the time mnstant of rccoveg. Only curves with 
%a t 
Ese;ereise Reeovery 
Figure 1. Example of oxygen consumption (Vo,) and carbon dioxide 
production (V<‘o,) curves during exercise and recovery Lt a control 
subject and P Fa&nt with stable dilated cardiomyopathy. EPVoL = 
half-recovery time of p& oxygen consumption; Total Vo, Ex = total 
oxygen consumption during exercise; Total Vo, Recuv = girl oxygen 
consumption dur;ag recovery. 
a cczfficient of correlation >(I.85 were selected for the detcr- 
mination of the time constant of recovery (n = 187). Because 
no indexes of recovery were clearly defined in published 
studies, we determined the following indexes (Fig. 1): 1) 
half-recovery time of peak oxygen consumption. defined as the 
time needed for peak oxygen consumption to decrease to its 
half value; 2) recovery time, defined as the time during 
recovery needed for the respiratory exchange ratio to become 
<I lC)r 220 continuous seconds; 3) total oxygen consumption 
during exercise and duting recovery, defined as the areas under 
oxygen consumption curves during exer&e and during recov- 
ery; and 4) time constant of recovery of oxygen consumption. 
We also calculated the ratio between the duration of exe&e 
and recovery lime and the ratin between total oxygen con- 
sumption during exercise and during recovery CR%,). 
St&&es. Results are presented as mean value 2 SD. 
Differences between groups were assessed by analysis of 
variance and by unpaired Student I tests followed by the 
Student-Newman-Keuls test. Discrete variables were com- 
pared using a chi-square analysis. Relation behveen variables 
were studied by a @ear regression analysis followed by a 
multilinear regression analysis. 
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Table 1. Clinical Characteristics of the 153 Study Patients With Dilated Cardiomyopathy and 
Differences Between Survivors and Nonsurvivors* 
study 
Patients 
(n = 153) 
Survivor5 Nonsurvivors’ p Value (survivors 
(n = 113) (n = 40) vs. nonsurvi~ors) 
fw (Yl) 50.1 _c 11.5 50.8 + 11.1 48.4 k 12.4 0.26 
Gender (h&F) 139114 103/10 3614 0.92 
NYHA II/ill 9657 Ro/33 16,24 O.oUl 
Etiology (Md/O) 64/76Il3 43m:10 21:16/3 0.28 
LV end-diastolic diameter (mm) 67.8 -t 8 65 f 7.4 71 c 8.7 i 0.00x 
LV ejection fr ction (5%) 39.8 f I2 32.7 2 11.8 22.6 t 9.5 -c o.ooo1 
Duration of exercise (s) 713 + 215 7Sb i 210 595 f 161 < O.oooI 
Vo, at AT (mUmin) 778% 337 824 + 333 641 2 321 0.003 
Peak VoL (ml/min) 1,220 + 44s 1,294 5 420 l~cs3! 2 446 o.con3 
Peak Voz (mt’min kg) per 15.7 c 4.9 16.6 5 4.6 13.2 2 4.8 O.OW 
5% predicted value Vo, 532 lb 57.7 5 I5 43 2 14.8 c o.ow 
Peak RER 1.26 + 0.12 1.26 + 0.12 1.27 + 0.12 0.65 
Peak VE (literrimin) 66.8 2 20 68.8 t 20.5 60.8 + 16.9 0.03 
Iwo2 2.38 2 1 2.56 2 1 1.87 2 79 0.OtM1 
‘/2pVOz(S) 128 + 61 125f58 139 2 67 0.21 
RT 6) 530 -c lb7 528 + 171 5.33 + 180 0.85 
RRT 1.48 -t 0.64 156 2 0.62 1.28 2 0.65 0.0155 
*Patients with cardiovascular death or heart transplantation. Data are prwnted as number of patients or mean 
value ? SD. AT = ailaerobic threshold; F = female; Id = idiopathic; Is = ischemic; LV = left ventricular; M = male; 
NYHA Ii/III -= New York Heart Assnciation functional class II or 111: 0 = other: RER = respiratory exchange .atio; 
RRT = rat5 between duration of exe+ and duration of recovety; RT = recovery time; RVo, = ratio betwee; total 
oxygen consumption during exercise and total oxygen cor,sumption during rcrovery; VE = minute ventilation; Vo, = 
oxygen consumption; ‘/zpV% = half-recovery time of peak oxgyen consumption. 
Follow-up was performed by direct examination or by 
contact with the general practitioner or the c.ardiologist. Major 
end points were cardiovascular death and heart transplanta- 
tion. The minimal follow-up period was 1 year unless a major 
end point terminated the follow-up. A Kaplan-Meier method 
was performed to estimate the cumulative survival. We strati- 
fied the population study into two subgroups on the basis of the 
median value of the variable tested, and a comparative log 
rank test was used to compare the survival rates of the two 
wbgroups. A multivariate Cox pn portional hazards analysis 
m performed to determine the independent predictors of 
event-free survival. Quantitative variables were entered as 
continuous variables. We performed two mult.‘v;,riate Cox 
proportional hazards analysis, the first with all patients and the 
second with a subgroup of patients with moderate exercise 
intolerance.. Because the first multivariate Cox analysis se- 
lected percent maximal predicted oxygen consumption as the 
most powerful index predicting survival, in the second analysis 
we classified the’ subjects into two subgroups according to 
percent maximal predicted oxygen consumption. Statistics 
were performed with the SAS software version 6.08. A p value 
~0.05 was considered statistically significant. 
Results 
Study gr@~p. We studied 153 patients (139 men, 14 
women) with a mean age of 50.1 2 11.5 years (range 21 to 75); 
their baseline characteristics are presented in Table 1. Patients 
were treated with angiotensin-converting enzyme inhibitors 
(96%), diuretic drugs (95.4%), digoxin (74.5%), amiodarone 
(28.1%), nitrates (56.2%), anticoagulant agents (35.3%), aspi- 
rin (37.9%), beta-adrenergic blocking agents (14.4%) and 
calcium channel antagonists (3.9%). 
Cardiopulmonary exercise test. Results of exercise and 
postexercise oxygen consumption in the different subgroups 
are presented in Table 2. All the indexes of recovery were 
significantly different between the subgroups. The RVo, was 
significantly reduced in paiients and all the indexes related to 
the duration of recovery (half-recovery time of peak oxygen 
consumption, recovery time, time constant of recovery and the 
ratio between the duration of exercise and recovery time) were 
longer in patients thap :n contml subjects. The only significant 
differences between young and old control subjects were the 
mean age and the peak oxygen consumption. The values for 
oxygen consumption at rest and ar the end of recovery were 
significantly less in the subgroups of patients with a peak 
oxygen consumption cl5 ml/min per kg (groups 2 and 3) than 
in control subjects. 
Regression analysis. The regression analysis was per- 
formed in the total study group (patients and control subjects, 
n = 208) (Fig. 2). The different regression coefficients are 
presented in Table 3. Peak oxygen consumption was well 
correlated with duration of exercise (r = 0.87) as was RVo, 
with ratio between the duration of exercise and recovery time 
(r = 0.89). The time constant of recovery was correlated with 
the half-recovery time of peak oxygen consumption (r = 0.63). 
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Tabte 2. Cardiopulmonary Exercise Test Results in 55 Control Subjects and 153 Patients With Dilated Cardiosyopathy 
Patients With Dilated Cardinmyopath) 
Group I Group 2 Gmup 3 
(peak Vo, 
215 mlimin 
(peak Vo? 
>I0 mumin 
(peak i’o, 
110 mUmin 0 Value 
Y0IUlg 
(n = 30) 
Old 
(n = 25) 
per kg) 
(0 = 79) 
Age w 25-t55 48.3 2 11.2’ 46% II 53.4 + 9 : 56,s 2 Il.W.# c 0.om1 
Duration of exercise (s) 1350 2 306 l,O7O lr 493 8%” 1% 619 I lO9$. 445 2 lll#.#;. ‘C o.aNn 
Rest heart rate (beatdminj 82.2 2 13.8 73.6 f 9.6 892 IS 83 = 19 % 2 19#.## .c II.CWl 
Peak heart rate (beats/min) Is4 2 11.7 157 + 22’ 157 r 24 137’26$., 135 f XT*‘.;; i 0.m1 
Recovery heart rate (kaWmin) 112 * 15.9 I05 f 1s 106 2 215 96T22.5 100’18.4 0.009 
Vo, at rest (mUmin) 216 i 77 w-c70 212 r 74 lS4Z758 179 = 71** O.Iy)S 
Vq at AT (ml/min) 1,708 It 733 1,444 2 a(3 930 ? 353f 713 2 202s.; 429 2 145#$$. c 0.fmo1 
Peak Vo, (ml/min) 2,798 2 863 2.198 2 865 1536 = z&f 1,010 + 153*. 63 I f I’li#.t$. I( O.WlI 
Peak Vo2 (ml/min kg) pr 41.6 2 9.9 31.4 z 11.8’ 19.6 2 3.2: 13 t If. 8.8 + 1.5#$:. < 0.ooo1 
‘3 prediied value Vo, to6 -+ 19.7 102 +_ 19.2 M.4 2 13t 47.6 f 9.6:. 33.7 ” 7.4#.$$, -c 0.oa11 
Peak RER 1.26 20.1 1.2 2 0.11 1.26 + 0.13 1.25 r 0.12 1.28 ?(I.13 0.W 
Peak VE (literslmin) 107 ? 32 89.6 + 37.8 76.7 i 19.5 58.7 +_ 1x$.: 51.3 2 14#.2 (1 .rxnl 
Peak WVq 31.4 2 5.5 343rS 40 z 6.7: 47 r 8.?i, 65 + 11 #.if. -r 0.cc41 
RV% 5.77 2 2.34 4.81 L 2.8 2.9 t 0.9: 2 2 0.63.:. 1.38 z OMf.$~. < lMooI 
‘4VO2 (9 67.7 2 265 89 + 39 108 L 44.6 137 : %.7fl 1’6 2 75#.$i ‘: o.Ix*l 
RT (9 431 -t 135 465 f 173 522Z169 531 + 15’) 555 f 201 0.024 
RRT 3.5 + 1.61 2% + 2.28 1.78 C 0.6t 1.27 2 0.46& 0.95 + 053t.s ‘f c O.cx)ul 
Vo, at RT (mumin) 375 t- 215 3O3 + 169 2.512 110 1% 2 61t.t 175 : 71”.@ : o.alo1 
tRec (s) 76.5 t 26.4 68.9 2 36 127 2 121 14Or72$ 39 2 156#,M < O.oool 
*p c OMJOI (old vs. young control subjects). tp < 0.01 (Group 1 vs. old oontml subjects). tp < O.OC@l, Pp < 0.002 (Group 2 vs. old control subjects). / p < O.(Ioul. 
Yp < O.OO2 (Gmup 2 vs. Group 1). #p < O.Mll, **p < 0.003, ttp = 0.01 (Group 3 vs. old control subjectsj. $$p i O.WlI. B p = O.M7 (Group 3 M. Group 1). /I Ip < 
O.ooOl, ??p < 0.009, ##p = 0.007 (Group 3 vs. Group 2). ANOVA = analysis of variance; AT = anaerobic threshold: RER = rqiratory exhange ratio: RRT = ratii 
between duration of excrc:sZ and duration of recovery; RT = recovery time; RVo, = ratio between total oxygen coxwmption during rxerrise and total oqgen 
wnsumption during recover; tRec = time constant of recover of oxygen consumption; Vco, = ca&m dioxide production: VE = minute rea’ilation: Vo, = ~m;gen 
commnption; %pVo, = half-recovery time of peak ongyen consumption. 
In multiple regression analysis (including the indexes related to 
the duration of recovery and age), the most closely correlated 
index of recovery with peak oxygen consumption was the ratio 
between the duration of exercise and recovery time (F = 142, 
p < O.OOOl), followed by the recovery time (F = 40, p < 
O.OOOl), age (F = 28, p < 0.0001) and the half-recovery time of 
peak oxygen consumption (F = 11.5, p = 0.009). 
SurvIvaI artaIysI.s. During a median follow-up period of 
439 days (range 26 to 1,293) there were 24 cardiovascular 
deaths and 16 heart transplantations. One patient was lost to 
follow-up and two deaths were related to cancer. At the end of 
follow-up, cardiovascular mortality was 15.7% and, including 
heart transplantation, the event rate was 26%. For the 153 
patients with dilated cardiomyopathy, the survival rate was 
97.4%, 90.2% and 87.6% at 6,12 and 18 months, respectively. 
If heart transplantations were included, the event-free survival 
rate was 91.5%, 83% and 77.8%, respectively (Fig. 3). 
The differences between survivors and ‘non survivors” 
(which induded patients with heart transplantation) are sum- 
marized in Table 1. Table 4 shoivs the results of univariate and 
multivariate analysis for the 153 patients with dilated cardio- 
myopathy. The multivariate Con analysis selected percent 
maximal predicted peak oxygen consumption (p = 0.003) and 
ejection fraction (p = 0.03) as independent predictors of 
survival. Peak oxygen consumption normalized for body weight 
was not an independent predictor of survival. 
Patients were classified according to percent maximal pre- 
dicted oxygen consumption. Among the 35 patients with a 
percent maximal predicted peak oxygen consumption <40%, 
the event rate was 60% at the end of the follow-up period 
(median 336 days, range 26 to 1.038) with 10 cardiac deaths 
and 11 heart transplantations. The mean age of the patients 
was 50.9 C 12.5 years; 12 patients were in functional class II 
and 23 in class III. Mean left ventricular ejection fraction was 
22.8 2 10.8%. percent maximal predicted peak oxygen con- 
sumption was 34.2 t 5.7% and peak oxygen consumption was 
10.3 t 2.6 mumin per kg. In this subgroup. event-free survival 
was 71.4% at 6 months, 54.3% at iL months and 46% at 18 
months (Fig. 3). 
Among the 118 patients with moderate exercise intoler- 
ance, there were 14 cardiac deaths and 5 heart transplantations 
at a median follow-up period of 500 days (range 50 to 1293). 
The mean age was 49.9 + 11.7 years; 84 patients were in 
functional class II and 34 were in class III. Mean left ventric- 
ularejection fraction was 32 2 t 11.5%, peak oxygen consump 
tion was 17.3 C 4.2 ml/min per kg and percent maximal 
predicted peak oxygen consumption was 59.7 -C 13.4%. Event- 
free survival at 6,12 and 18 months was 975.92.4 and 873%, 
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R = 0.69 
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Figure 2. Scatterplots showing all individual values (patients 
with dilated cardiomyopathy and control subjects, n = 208) 
for indexes of recovery and peak oxygen consumption (peak 
Vo,). Top, Ratio behveen exercise duration and recovery time 
(RRT) plotted against peak Voz. Middle, Half-recovery time 
of peak oxygen consumption (EPeakVoJ plotted against 
peak oxygen consumption. Bottom, Ratio behveen total oxy- 
gen consumption during exercise and total oxygen consump- 
tion during recovery (RVo,) plotted against ratio between 
exercise duration and recovery time. 
respectively (Fig. 3). Table 5 shows the results of the univariate 
and muitivariate analysis in this subg-oup. Mtthivariate Cox 
analysis selected only two independet, predictors oi survival: 
RVoz (p = 0.013) and ejection fraction (p = 0.013). Figure 4 
shows the survival curve in this subgroup of patients stratified 
by RVo, (>2.5 or ~2.5) and by ejection fraction (>Bt% or 
<30%). The median value of RVoz was 2.5. In this subgroup, 
14 patients (74%) with a major event had an RVo, c2.5. 
Survival is better when RVoz is >2.5, whatever the value of the 
ejection fraction. 
Discussion 
Our study demonstrates in a large group of patients with 
stable dilated cardiomyopathy that the kinetics of oxygen 
consumption during recovery are delayed compared with val- 
ues in a control group. Moreover, RVo?, an index analyzing 
exercise and recovery periods, predicts survival in a subgroup 
of patients with moderate risk of major cardiac events. 
Indexes of recovery. In normai subjects. oxygen consump 
tion after maximal exercise shows an exponential, decline 
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Tahoe 3. Rrgession Coefficientc Between Indexes of Recovery and 
Variables of Exercise, Age and Left Ventricular Ejection Fraction in 
153 Patients With Dilated Car&myopathy and 55 Control Subjectc 
Age 
w LVEF’ Peak Vo, 
Exercise 
Duration 
RVo, -0.53 0.17 - 036 
‘Yzp?02 0.42 -0.17 -0.4s -0.46 
RT 0.24 0.16 -0.24 -0.22 
RRT -0.48 0.01 0.71 - 
tRect 0.23 0.09 -0.29 -0.26 
*n = 153. fn = 187. LVEF = left ventricular ejection fraction: RRT = ratio 
between duration of exercise and duration of recovery: RT = recovery time: 
RVo, = ratio between total oxygen consumption during exercise and :otal 
oxygen consumption during recovery; iRzc = tinle constant of recovery: Vo, = 
oxygen consumption; ‘%pVo2 = half-recovery time of peak oxygen consumption; 
-= not performed. 
toward the rest baseline level (6,7). In previous studies (9-12), 
the kinetics of oxygen consumption were studied during a short 
recovery Period (2 to 4 min), in a limited number of patients 
(15 to 72) and control subjects (CM) or after submaximal 
exercise. We defined several indexes analyzing the recovery 
period alone (half-recovery time of peak oxygen consumption. 
recovery time and the time constant of recovery) but also 
indexes analyzing the exercise and the recovery periods (ratio 
between the duration of exercise and recovery time and 
RVo,). RVo,, the ratio between total oxygen consumption 
during exercise and during recovery, gives a good idea of the 
relation between oxygen, consumption during exercise and 
during recovery. The mechanism of the rf-every of oxygen 
consumption is not fully understood. Indexes of recovery were 
not correlated with ejection fraction, suggesting that the 
kinetics of oxygen consumption during recovery were mainly 
related to peripheral factors. Patients with congestive heart 
failure have reduced oxygen stores, impaired oxygen transport 
and muscle metabolism as well as muscle atrophy (15-19). The 
mechanism underlying exercise intolerance is probably the 
same as the one explaining the delay in recovery. The decline 
in oxygen consumption is subdivided into a fast component 
followed by a slow one (7). The half-recovery time of peak 
oxygen consumption (and the time constant of recovery) 
Fire 3. Event-free sttrvivtal curves for the total study group (bold 
line) and for the subgroups of patients with a percent maximal 
predicted oxygen consumption (Vo,) ~40% (lit line) or <GO% 
($lashr!d he). 
too - 
Table 4. Predictors of Event-Free Survival in the 153 Patients With 
Dilated Cardiomvooathv 
Umvariate 
An&is 
Multivariate 
An+is 
Age 
Etiology 
NYHA clau 
LV end-diastolic diameter 
LV ejection fraction 
Duration of exercise 
Peak Vo, (mlmin per kg) 
52 predicted value Vo2 
RVo, 
‘2pV02 
RT 
RRT 
rl.22 
tJ.034 
o.au3 
0.016 
o.aJ0f 
0.025 
&Ml1 
O.U(k)l 
0.IY3 
0.c-l 
I).!9 
0.w 7 
0.6X 
0.32 
0.57 
0.45 
0.03 
0.3Y 
0.25 
o.av 
0.15 
0.1 
ml 
IQ!+ 
LV = left ventricular ejection fraction: XYHA class = New York Heart 
Aswiation functional class. RRT = ratio hhreen duration of exerciw and 
duration of recovery; RT = recovery ime: R\‘o, = ratio hetwcen total oqgen 
consumption during exercis and totAl oayeen consumption during . . covery; 
Vq = o.xygen consumptiw ‘qSnl = half-rccove?; time of peal oqen 
cwsumprion. 
studies the fast component and the recovery time studies the 
fast and the slow components. The fast component seems to be 
related to the resynthesis of pbosphocreatine and oxygen 
stores (7). Gjhen-Solal et al. (12) found a good correlation 
between the half-recovery time of peak oxygen consumption 
and the half-recovery time of the PiiCr ratio of the anterior 
muscle leg. The mechanism of the slow component is not 
understood. There is no relation between the slow comF.ment 
and the excess production of lactates (20.21) or the increase in 
catecholamines (11). In our stu.ly. patients with a peak cqgen 
cousumption 45 ml/min per kg (groups 2 and 3) had signif- 
icantly lower values for oxygen consumption at resi (baseline) 
and at the end of recovery than did control subjects and 
patients in group 1. This could explain the delay of the sknv 
component of recovery, but further studies are required to 
Table 5. Predictors of Elent-Free Survival in the 118 Patients With 
Moderate Exercise Intolerance 
Multivariate 
Adpi 
Age 
Etiolo~ 
WHA class 
LV end-diastolic diameter 
LV ejection fraction 
Duration of r.wrciw 
Peak \02 (mlirnin per 4) 
‘; prediited value Vo, 
RVo, 
‘2pV0, 
RT 
RRT 
Abbreviations as in Table 4. 
u.2 it.37 
!J.rn 1J.W 
0.57 0.35 
0.43 0.43 
0.03 0.013 
0.:3 0.34 
II.13 0.w 
l1.W 0.45 
RO42 0.013 
0.65 0.048 
0.73 0.4 
03 0.1 
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Figure 4. Event-free survival curves for the subgroup of patients with 
moderate exercise intolerance (percent maximal predicted oxygen 
consumption [Vo,] >40%). Top, Patients stratified by the median 
value of the ratio between total oxveen consumntion durine exercise 
and during recovery (RVo, ~2.5 0;>2.5). B&m, Patients-stratified 
by the median values for both left ventricular ejection fraction (EF 
~30% or >30%) and RVoZ ~2.5 or >2.5. 
understand why these patients had lower values for oxygen 
consumption at rest. 
The level of fitness and age could modilj the kinetics of 
oxygen consumption. Training increases the rate of recovery in 
normal subjects (22), and a similar response is expected in 
patients with congestive heart failure in whom muscle decon- 
ditioning remains a major problem. Age plays a role in 
determining exercise capacity and recovery of oxygen con- 
sumption, but its role is probably not dominant. There were 
significant differences in indexes of recovery between old 
control subjects and patients despite similar mean age. In 
contrast, all the indexes of recovery were similar in young and 
old control subjects. 
Smvlval analysis. One important finding of our study is 
that peak oxygen consumption normalized for body weight was 
not an independent prognostic marker when it was compared 
with percent maximal predicted oxygen consumption. ‘Pre- 
dieted value of maximal oxygen consumption, lvhich takes into 
account age, gender, height and weight, is more precise than 
peak oxygen consumptiottikg (14). In most previous studies, 
percent maximal predicted oxygen consumption was not com- 
pared with peak oxygen consumption/kg (3-523-25). Re- 
cently, Di Salvo et al. (26) demonstrated in patients referred 
for heart transnlantation (functional class III or IV) that 
percent maximal predicted oxygen consumption was’more 
powerful than peak oxygen consumption&g for predicting 
survival (26). In patients with dilated cardiomyopathy in stage 
II to IV (New York Heart Association classification) percent 
maximal predicted oxygen consumption is a more powerful 
predictor of cardiac events than peak oxygen consumption 
normalized for body weight. Moreover. it is also more powerful 
than left ventricular ejection fraction. which is a good predictor 
of survival (23,24,27,28). 
However, in a subgroup of patients with a low risk of major 
cardiac events, percent maximal predicted oxygen consump- 
tion and peak oxygen consumption/kg failed to predict survival. 
The prognostic information given by peak oxygen consumption 
is evident when the value is ~1tJ ml/min per kg (3,4,27,29). In 
our subgroup of patients with a percent maximal predicted 
oxygen consomption :40%, mean peak oxygen consump- 
tion/kg was 10.3 2 2.6 mlimin per kg. This cutoff value (40%) 
selected the most severely il l patients with a cardiovascular 
event rate of 45.7% at I year. Heart transplantation repre- 
sented 52.4% of these cardiovascular events. It is possible that 
the result of the cardiopulmonary exercise test guided the 
physicians in patient management. In patients with a percent 
maximal predicted oxygen consumption >4O%, the event-free 
survival rate was 92.4% at I2 months. Despite this low event 
rate, the only index of the exercise test that provided prognos- 
tic information was RVo,. RVo, analyzes the kinetics of 
oxygen consumption during exercise and during recovery. 
Figure 4 clearly shows that survival is better in patients with an 
RVo, >2.5 than in patients with an RVoz ~2.5, whatever the 
value of ejection fraction. A patient with a moderate exercise. 
intolerance and with a short recovery period has a better 
prognosis than a patient with a long recovery period. We 
recommend that RVo, be determined in all patients with 
moderate exercise intolerance (percent maximal predicted 
oxygen consumption >40%) to increase the prognostic value 
of the results of the cardiopulmonaty exercise test. Patients 
with an RVoz C2.5 must be followed up carefully because of 
the increased risk of major cardiac events. in patients with a 
percent maximal predicted oxygen consumption <40%, RVo2 
or other indexes of recovety are not useful. 
Limitations of the stud?. Exercise was performed on a 
bicycle with a progressive protocol. Our results cannot be 
extrapolated to other protocols (treadmill test) or to other 
patients (hospitalized, functional class IV). Our survival anal- 
ysis was retrospective and focused on functional class, left 
ventricular ejection fraction at rest and results of the cardio- 
pulmouaty exercise test. Some indexes such as hemodynamic 
variables, hormonal activation or ventricular arrhythmias were 
not included in our analysis. One goal of our study was to 
compare the prognostic information of indexes of recovery to 
well known prognostic markers (i.e., peak oxygen consumption 
and left ventricular ejection fraction) in ambulatory patients 
with dilated cardiomyopathy. A large prospective study in 
patients with moderate exercise intolerance is required to 
confirm our results on survival. However, we think that our 
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results are valid because we studied the recovery of oxygen 
consumption in a large group of patients with dilated cardio- 
myopathy and with a wide range of exercise intolerance. 
Coeclosinos. Our study demonstrates that 1) the kinetics 
of oxygen consumption aiter maximal exercise were delayed in 
patients with stable dilated cardiomyopathy compared to con- 
trols and this delay was related to the degree of exercise 
intolerance; 2) for all patients, percent maximal predicted 
value of oxygen consumption and left ventricular ejection 
fraction were independent predictors of survival; 3) in patients 
with moderate exercise intolerance (peak oxygenconsumption 
>40%), RVo2 and left ventricular ejection fraction were 
independent predictors of survival. 
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